Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Tracon Pharmaceuticals, Inc. (TCON)
Sector: Healthcare; Industry: Biotechnology

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). The company also develops TRC102, a small molecule that is in Phase II clinical trial for mesothelioma, Phase I clinical trial for solid tumors and lung cancer, and Phase I/II clinical trial for solid tumors and lymphomas; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trial for the treatment prostate cancer. The company has license agreements with Ambrx, Inc.; Santen Pharmaceutical Co. Ltd.; Roswell Park Cancer Institute and Health Research Inc.; Case Western Cancer Center; and Lonza Sales AG, as well as a cooperative research and development agreement with National Cancer Institute. TRACON Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-08 Brown Scott B. Chief Financial Officer Buy 1,000 $8.30 $8,296 No
2021-01-27 THEUER CHARLES President and CEO Buy 11,000 $8.98 $98,771 No
2020-12-30 Ikarian Capital, LLC Member of 10% Group Buy 520,291 $9.61 $4,999,997 No
2020-12-29 WIGGINS MARK C Chief Business Officer Buy 1,000 $10.57 $10,570 No
2020-12-22 Opaleye Management Inc. 10%-Owner Buy 496,277 $8.06 $3,999,993 No
2020-11-11 Ikarian Capital, LLC Member of 10% Group Buy 34,000 $5.10 $173,269 No
2020-10-21 Opaleye Management Inc. 10%-Owner Buy 8,656 $4.40 $38,060 No
2020-10-21 THEUER CHARLES President and CEO Buy 2,000 $4.38 $8,769 No
2020-09-24 Opaleye Management Inc. 10%-Owner Buy 78,734 $4.73 $372,095 No
2020-09-23 THEUER CHARLES President and CEO Buy 5,000 $4.72 $23,599 No
2020-09-11 Ikarian Capital, LLC Member of 10% Group Buy 322,471 $3.28 $1,057,387 No
2020-09-11 Ikarian Capital, LLC Member of 10% Group Buy 322,471 $3.28 $1,057,387 No
2020-09-10 WIGGINS MARK C Chief Business Officer Buy 7,000 $4.14 $28,953 No
2020-09-09 Opaleye Management Inc. 10%-Owner Buy 56,558 $3.38 $190,902 No
2020-09-04 THEUER CHARLES President and CEO Buy 10,000 $2.58 $25,750 No
2020-09-02 Opaleye Management Inc. 10%-Owner Buy 159,800 $2.28 $363,825 No
2020-08-31 Opaleye Management Inc. 10%-Owner Buy 545,504 $1.74 $950,378 Yes
2020-08-21 THEUER CHARLES President and CEO Buy 5,325 $1.56 $8,307 No
2020-08-20 THEUER CHARLES President and CEO Buy 30,000 $1.58 $47,400 No
2020-08-18 THEUER CHARLES President and CEO Buy 44,843 $1.63 $73,021 No
2020-08-13 THEUER CHARLES President and CEO Buy 20,000 $1.73 $34,500 No
2020-06-24 THEUER CHARLES President and CEO Buy 9,895 $1.90 $18,800 No
2020-06-15 PELLETIER SAUNDRA L Director Buy 5,500 $2.04 $11,209 Yes
2020-05-22 THEUER CHARLES President and CEO Buy 10,592 $1.90 $20,119 No
2020-03-13 THEUER CHARLES President and CEO Buy 4,100 $1.13 $4,624 No
2020-03-12 THEUER CHARLES President and CEO Buy 20,000 $1.43 $28,639 No
2020-03-10 THEUER CHARLES President and CEO Buy 10,000 $1.87 $18,691 No
2020-01-23 WIGGINS MARK C Chief Business Officer Buy 5,000 $4.02 $20,102 No
2019-12-09 Puissance Cross-Border Opportunities V LLC 10%-Owner Sell 384,130 $2.93 $1,127,379 No
2019-08-09 THEUER CHARLES President and CEO Buy 50,000 $0.45 $22,500 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.